Here at Touch Medical Media we are supporting World AIDS day (1st December 2021), to raise awareness and help improve health and wellbeing for patients living with HIV and AIDS.
We had the pleasure to talk to Dr Marta Boffito (Chelsea and Westminster Hospital and Imperial College, London, UK) about HIV screening and early initiation of antiretroviral therapy, and what clinicians can do to ensure long-term adherence to therapy and sustained quality of life for people living with HIV.
1. Why is early ART initiation important and how can it be achieved in clinical practice?
2. What are the barriers to antiretroviral therapy initiation and how can they be overcome to maximize adherence?
3. How does living with HIV affect quality of life and what factors negatively impact adherence to therapy in the long term?
Disclosures: Dr Marta Boffito has been a speaker/advisor for ViiV Healthcare, GlaxoSmithKline, Gilead, Mylan, and Cipla. Dr Marta Boffito has also received research grants from ViiV Healthcare, GlaxoSmithKline, Gilead, Mylan, Novavax, Valneva, and Roche.
Support: The production of this video was supported by Touch Medical Media.
Other content available in support of World AIDS Day includes:
Share this Video
Related Videos In HIV
Moti Ramgopal, IDWeek 2022: Unmet needs and challenges around maintenance of HIV-1 virologic suppression
In this touchINFECTIOUS DISEASES interview, we met with Dr Moti Ramgopal (Midway Research Center, FL, USA) to discuss the unmet needs and challenges around maintenance of HIV-1 virologic suppression. Dr Ramgopal discusses challenges around stigma, social issues, tolerability, injection site reactions, and patient satisfaction with their current treatment regimen. Access an interview with Dr Moti […]
Moti Ramgopal, IDWeek 2022: Phase 3/3b FLAIR and ATLAS-2M pooled analysis – Efficacy and safety outcomes through week 96 by race
Long-acting cabotegravir + rilpivirine administered monthly or every 2 months is the first and only complete long-acting regimen recommended by treatment guidelines for the maintenance of HIV-1 virologic suppression. In this touchINFECTIOUS DISEASES interview, we met with Prof. Moti Ramgopal (Midway Research Center, FL, USA) to discuss a post hoc analysis of pooled outcomes for […]
Marina Klein, AIDS2022: Global health burden and the elimination of HIV, hepatitis B, and hepatitis C
There are number of challenges in the elimination of the three blood-borne viruses — HIV, hepatitis B (HBV), and hepatitis C (HCV). Treatment advances have been made with the introduction of highly effective antiviral agents into clinical practice, and prevention strategies. However, for worldwide elimination of these viruses, effective vaccines are required. Dr Marina Klein […]
Journal articles and more to your inbox
Get the latest clinical insights from touchINFECTIOUS DISEASESSign me up!